Luca A. Petruccelli

893 total citations
9 papers, 690 citations indexed

About

Luca A. Petruccelli is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Luca A. Petruccelli has authored 9 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Hematology and 2 papers in Oncology. Recurrent topics in Luca A. Petruccelli's work include Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Protein Degradation and Inhibitors (2 papers). Luca A. Petruccelli is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Protein Degradation and Inhibitors (2 papers). Luca A. Petruccelli collaborates with scholars based in Canada, United States and France. Luca A. Petruccelli's co-authors include Wilson H. Miller, Benoı̂t Viollet, Michaël Pollak, Carolyn Algire, Elena Birman, Olga Moiseeva, Lilian Amrein, Xavier Deschênes‐Simard, Gerardo Ferbeyre and Filippa Pettersson and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Luca A. Petruccelli

8 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca A. Petruccelli Canada 7 560 149 98 80 63 9 690
Anne Aries France 13 460 0.8× 119 0.8× 44 0.4× 101 1.3× 33 0.5× 21 718
Minghai Shao China 17 282 0.5× 105 0.7× 123 1.3× 50 0.6× 49 0.8× 30 647
Moulun Luo United States 17 649 1.2× 134 0.9× 78 0.8× 56 0.7× 43 0.7× 32 830
Youngtae Jeong United States 11 504 0.9× 190 1.3× 199 2.0× 69 0.9× 93 1.5× 20 805
Renata Windak Poland 6 413 0.7× 69 0.5× 164 1.7× 107 1.3× 65 1.0× 18 689
Carole Ferraro‐Peyret France 13 300 0.5× 113 0.8× 86 0.9× 47 0.6× 118 1.9× 28 673
Mahnaz Bonrouhi Germany 14 493 0.9× 114 0.8× 127 1.3× 134 1.7× 210 3.3× 21 947
Noga Gadir United States 10 696 1.2× 99 0.7× 186 1.9× 42 0.5× 50 0.8× 18 871
Heidelinde Jäkel Austria 12 453 0.8× 281 1.9× 70 0.7× 108 1.4× 24 0.4× 16 687
Ming Qiu China 16 591 1.1× 386 2.6× 146 1.5× 45 0.6× 86 1.4× 35 1.0k

Countries citing papers authored by Luca A. Petruccelli

Since Specialization
Citations

This map shows the geographic impact of Luca A. Petruccelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca A. Petruccelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca A. Petruccelli more than expected).

Fields of papers citing papers by Luca A. Petruccelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca A. Petruccelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca A. Petruccelli. The network helps show where Luca A. Petruccelli may publish in the future.

Co-authorship network of co-authors of Luca A. Petruccelli

This figure shows the co-authorship network connecting the top 25 collaborators of Luca A. Petruccelli. A scholar is included among the top collaborators of Luca A. Petruccelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca A. Petruccelli. Luca A. Petruccelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Elkrief, Arielle, Luca A. Petruccelli, Caroline Rousseau, et al.. (2021). Reasons for delay in timely administration of adjuvant chemotherapy for patients with stage III colon cancer: a multicentre cohort study from the McGill University Department of Oncology. BMJ Open Quality. 10(1). e000934–e000934. 5 indexed citations
2.
Robichaud, Nathaniel, Sonia V. del Rincón, Bonnie Huor, et al.. (2014). Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3. Oncogene. 34(16). 2032–2042. 205 indexed citations
3.
Petruccelli, Luca A., et al.. (2013). Sistema di valutazione della sostenibilità del packaging alimentare. Archives of Osteoporosis. 14(1). 110–119. 1 indexed citations
4.
Petruccelli, Luca A., et al.. (2013). Expression of Leukemia-Associated Fusion Proteins Increases Sensitivity to Histone Deacetylase Inhibitor–Induced DNA Damage and Apoptosis. Molecular Cancer Therapeutics. 12(8). 1591–1604. 21 indexed citations
5.
Petruccelli, Luca A., Manuel Flores Molina, Zuanel Diaz, et al.. (2013). The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells. Leukemia. 27(11). 2220–2228. 16 indexed citations
6.
Algire, Carolyn, Olga Moiseeva, Xavier Deschênes‐Simard, et al.. (2012). Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage. Cancer Prevention Research. 5(4). 536–543. 288 indexed citations
7.
Petruccelli, Luca A., et al.. (2011). Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells. PLoS ONE. 6(6). e20987–e20987. 107 indexed citations
8.
Cesare, Sebastian Di, et al.. (2010). Lysyl oxidase expression and inhibition in uveal melanoma. Melanoma Research. 20(2). 97–106. 23 indexed citations
9.
Laurenzana, Anna, Luca A. Petruccelli, Filippa Pettersson, et al.. (2008). Inhibition of DNA Methyltransferase Activates Tumor Necrosis Factor α–Induced Monocytic Differentiation in Acute Myeloid Leukemia Cells. Cancer Research. 69(1). 55–64. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026